Jubilant Pharmova Limited has announced a leadership transition in its finance department. Mr. Arun Kumar Sharma has relinquished his role as Chief Financial Officer, effective at the close of business hours on May 22, 2026, to transition into a new position as Advisor to the Chairmen. Concurrently, the company has appointed Mr. Ashish Mukkirwar as the new Chief Financial Officer and Key Managerial Personnel, effective May 23, 2026.
Leadership Transition in Finance
Jubilant Pharmova Limited has officially confirmed a change in its top financial management. Mr. Arun Kumar Sharma, who served as the Chief Financial Officer, has stepped down from his position as of May 22, 2026. Following his tenure as CFO, the company has confirmed that he will move into a strategic advisory role as Advisor to the Chairmen. The Board of Directors has formally placed on record its appreciation for his valuable contributions to the company during his term.
Appointment of New CFO
Succeeding Mr. Sharma, the Board of Directors has approved the appointment of Mr. Ashish Mukkirwar as the new Chief Financial Officer and Key Managerial Personnel (KMP) of the company, effective May 23, 2026. This appointment follows the recommendation of the company’s Nomination, Remuneration and Compensation Committee and the Audit Committee.
Background of Ashish Mukkirwar
Mr. Ashish Mukkirwar is a veteran financial leader with over two decades of experience spanning corporate finance, business finance, capital markets, investor relations, and M&A. Before joining Jubilant Pharmova, he served at Glenmark Pharmaceuticals, most recently as Group Vice President & CFO for their Global Formulations Business. His career also includes senior roles at Moelis & Company and UBS Investment Banking. He holds an MBA from the Indian Institute of Management, Kolkata, and brings extensive expertise in driving long-term strategic growth and stakeholder value.
Source: BSE
